Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications

Treatment continuation rates during maintenance reached up to 80%. Most switches involved a different mode-of-action. While conventional medications were tapered, IS and 5-ASA may support treatment continuation.